Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, TX, USA.
Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA; Section of Cardiovascular Research, Heart, Vascular and Thoracic Department, Cleveland Clinic Akron General, Akron, OH, USA.
Indian Heart J. 2020 Sep-Oct;72(5):337-344. doi: 10.1016/j.ihj.2020.08.015. Epub 2020 Sep 6.
Several registries and quality improvement initiatives have focused on assessing and improving secondary prevention of CVD in India. While the Treatment and Outcomes of Acute Coronary Syndromes in India (CREATE), Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF), and Trivandrum Heart Failure (THF) registries are limited to collecting data, the Tamil Nadu-ST-Segment Elevation Myocardial Infarction (TN-STEMI) program was aimed at examining and improving access to revascularization after an ST-elevation myocardial infarction (STEMI). The Acute Coronary Syndromes: Quality Improvement in Kerala (ACS-QUIK) study recruited hospitals from the Kerala ACS registry to assess a quality improvement kit for patients with ACS while the Practice Innovation and Clinical Excellence India Quality Improvement Program (PIQIP) provides valuable data on outpatient CVD quality of care. Collaborative efforts between health professionals are needed to assess further gaps in knowledge and policy makers to utilize new and existing data to drive policy-making.
一些注册研究和质量改进计划专注于评估和改善印度的 CVD 二级预防。虽然印度急性冠脉综合征的治疗和结局（CREATE）、印度心律学会-心房颤动（IHRS-AF）和特里凡得琅心力衰竭（THF）注册研究仅限于收集数据，但泰米尔纳德邦 ST 段抬高型心肌梗死（TN-STEMI）项目旨在检查和改善 ST 段抬高型心肌梗死（STEMI）后的血运重建机会。急性冠脉综合征：喀拉拉邦质量改进（ACS-QUIK）研究招募了喀拉拉邦 ACS 注册研究中的医院，以评估 ACS 患者的质量改进工具，而实践创新和临床卓越印度质量改进计划（PIQIP）则提供了有关门诊 CVD 护理质量的宝贵数据。需要卫生专业人员之间的协作努力来评估知识和政策制定者的差距，以利用新的和现有的数据来推动决策制定。
